October 27, 2016 — Abiomed Inc. said the U.S. Food and Drug Administration (FDA)gave approval for a prospective ...
A smartphone application developed by researchers at the University of Turku, Finland, can detect myocardial infarction, commonly known as a heart attack. No extra equipment is required for the app as it utilizes the phone's built-in motion sensors, especially the gyroscope. Therefore, the used technology is largely similar to the app for detecting atrial fibrillation that the research group announced in August. The myocardial infarction detection app should be available for test use in 2017.
For the first time, fetal medicine experts have performed prenatal heart surgery to remove a life-threatening tumor, called intrapericardial teratoma. The patient, who underwent the operation at 24 weeks of gestation while in his mother’s womb, is now a healthy three-year-old preschooler.
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
The healthcare industry’s transition to value-based care leaves no room for waste, and yet we know that inefficiency in ...
Svelte Medical Systems Inc. announced this week it received CE Mark certification of the Direct Sirolimus-Eluting Coronary Stent Rapid-Exchange (RX) System for the treatment of coronary artery disease. The first patient to receive Direct RX was treated by Auke Weevers, M.D., a practicing interventional cardiologist at Albert Schweitzer Ziekenhuis in Dordrecht, The Netherlands.
This video, provided by Zoll, demonstrates how cardiologists can explain sudden cardiac death to patients. It is ...
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
October 28, 2016 – Tryton Medical Inc., a primary developer of stents to treat coronary bifurcation lesions, and ...
With quality of care and cost efficiency at the top of your mind, there is no room in your hospital for waste from high ...
October 28, 2016 — Medicure Inc. recently received U.S. Food and Drug Administration (FDA) market clearance for its new ...
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
Acutus Medical announced the completion of the first patient procedure in the “Utilizing Novel Dipole Density Capabilities to Objectively Visualize the Etiology of Rhythms in Atrial Fibrillation” (UNCOVER-AF) clinical study. The study will evaluate the incidence of device and procedure-related safety, effectiveness and efficiency using the AcQMap High Resolution Imaging and Mapping System to guide ablation in persistent atrial fibrillation (AF) patients.
Volume matters when it comes to who does certain procedures to removing heart-attack causing blockages from arteries, according to a new study published recently in JACC: Cardiovascular Interventions.
October 27, 2016 — Corindus Vascular Robotics Inc. announced it received 510(k) clearance from the U.S. Food and Drug ...
Change Healthcare Cardiology Hemodynamics is an integrated hemodynamic monitoring system for monitoring vital signs and ...
The volume of information attendees receive at the annual Transcatheter Cardiovascular Therapeutics (TCT) interventional ...
October 27, 2016 — BioTrace Medical Inc. said it received U.S. Food and Drug Administration (FDA) 510(k) clearance for ...
Philips recently announced its latest image guidance solutions to be featured at the 2016 Transcatheter Cardiovascular Therapeutics meeting (TCT) in Washington, D.C., Oct. 29 – Nov. 2, 2016. Highlights will include the introduction of instant wave-Free Ratio (iFR) co-registration, which integrates iFR pullback data with the angiogram, and the third generation of HeartNavigator, live image guidance software for advanced structural heart disease procedures.